Fol. Biol. 2019, 65, 265-274
https://doi.org/10.14712/fb2019065050265
Metronidazole Attenuates the Intensity of Inflammation in Experimental Autoimmune Uveitis
References
1. 2000) Identification of a new epitope of human IRBP that induces autoimmune uveoretinitis in mice of the H-2b haplotype. Invest. Ophthalmol. Vis. Sci. 41, 127-131.
, D., Silver, P. B., Chan, C.-C., Wiggert, B., Caspi, R. R. (
2. 2002) Downregulation of intestinal lymphocyte activation and Th1 cytokine production by antibiotic therapy in a murine model of Crohn’s disease. J. Immunol. 169, 5308-5314.
< , G., Marini, M., Moskaluk, C. A., Odashima, M., Ross, W. G., Rivera-Nieves, J., Cominelli F. (https://doi.org/10.4049/jimmunol.169.9.5308>
3. 2016) Doxycycline, metronidazole and isotretinoin: do they modify microRNA/mRNA expression profiles and function in murine T-cells? Sci. Rep. 6, 37082.
< , E., Bengs, S., Aluri, S., Opitz, L., Atrott, K., Stanzel,C., Castro, P. A. R., Rogler G., Frey-Wagner, I. (https://doi.org/10.1038/srep37082>
4. 2011) Negative regulation of Toll-like receptor signaling plays an essential role in homeostasis of the intestine. Eur. J. Immunol. 41, 182-194.
< , A., Wilmanski, J., Forsman, H., Hrncir, T., Hao, L., Tlaskalova-Hogenova, H., Kobayashi, K. S. (https://doi.org/10.1002/eji.201040479>
5. 2002) Constitutive retinal CD200 expression regulates resident microglia and activation state of inflammatory cells during experimental autoimmune uveoretinitis. Am. J. Pathol. 161, 1669–1677.
< , C., Hoek, R. M., Forrester, J. V., Liversidge, J., Sedgwick, J. D., Dick, A. D. (https://doi.org/10.1016/S0002-9440(10)64444-6>
6. 2004) High levels of IgG class antibodies to recombinant HSP60 kDa of Yersinia enterocolitica in sera of patients with uveitis. Br. J. Ophthalmol. 88, 247-250.
< , J. C., Vargas-Rodríguez, L., Grinberg-Zylberbaum, N., Reyes-López, M. A., Domínguez-López, M. L., Pablo-Velazquez, A., Cancino-Diaz, M. E. (https://doi.org/10.1136/bjo.2003.023390>
7. 2008) Mouse models of experimental autoimmune uveitis. Ophthalmic Res. 40, 169-174.
< , R .R., Silver, P. B., Luger, D., Tang, J., Cortes, L.M, Pennesi, G., Mattapallil, M. J., Chan, C. C. (https://doi.org/10.1159/000119871>
8. 2001) Effects of anti-tumour necrosis factor, interleukin-10 and antibiotic therapy in the indometacin- induced bowel inflammation rat model. Aliment. Pharmacol. Ther. 15, 1827-1836.
< , S., Liu, Z., De Greef, B., Rutgeerts, P., Ceuppens, J. L., Geboes, K. (https://doi.org/10.1046/j.1365-2036.2001.01111.x>
9. 2008) The clinical time-course of experimental autoimmune uveoretinitis using topical endoscopic fundal imaging with histologic and cellular infiltrate correlation. Invest. Ophthalmol. Vis. Sci. 49, 5458-5465.
< , D. A., Wertheim, M. S., Armitage, W. J., Nicholson, L. B., Raveney, B. J. E., Dick, A. D. (https://doi.org/10.1167/iovs.08-2348>
10. 1994) Immunomodulation of experimental autoimmune uveoretinitis: a model of tolerance induction with retinal antigens. Eye 8, 52-59.
< , A. D., Cheng, Y. F., Liversidge, J., Forrester, J. V. (https://doi.org/10.1038/eye.1994.10>
11. 2004) Degree, duration, and causes of visual loss in uveitis. Br. J. Ophtalmol. 88, 1159-1162.
< , O. M., Tehrani, N. N., Marr, J. E., Moradi, P., Stavrou., P., Murray, P. I. (https://doi.org/10.1136/bjo.2003.037226>
12. 2008) Evaluation of immunosuppression induced by metronidazole in Balb/c mice and human peripheral blood lymphocytes. Int. Immunopharmacol. 8, 341-350.
< , M., Mohammad, M. K., Bustanji, Y., Alkhatib, H., Abdalla, S. (https://doi.org/10.1016/j.intimp.2007.10.018>
13. 2018) Autoimmunity, autoinflammation, and infection in uveitis. Am. J. Ophthalmol. 189, 77-85.
< , J. V., Kuffova, L., Dick, A. (https://doi.org/10.1016/j.ajo.2018.02.019>
14. 2012) Potential infectious etiology of Behçet’s disease. Patholog. Res. Int. 2012, 595380.
, M., Colucci, R., D’Erme, A. M., Moretti, S., Lotti, T. (
15. 2012) Recombinant probiotic therapy in experimental colitis in mice. Folia Biol. (Praha) 58, 238-245.
, R., Palffy, R., Celec, P. (
16. 1977) Suppression of cell-mediated immunity by metronidazole. Int. Arch. Allergy Appl. Immunol. 54, 422-427.
< , I., Mahmoud, A. A. F., Warren, K. S. (https://doi.org/10.1159/000231857>
17. 2016) The microbiota determines susceptibility to experimental autoimmune uveoretinitis. J. Immunol. Res. 2016, 5065703.
< , J., Seidler Stangova, P., Klimova, A., Svozilkova, P., Hrncir, T., Stepankova, R., Kverka, M., Tlaskalova-Hogenova, H., Forrester, J. V. (https://doi.org/10.1155/2016/5065703>
18. 2011) Cytokines in autoimmune uveitis. J. Interferon Cytokine Res. 31, 733-744.
< , R., Caspi, R. R. (https://doi.org/10.1089/jir.2011.0042>
19. 2017) Gut microbiota linked to autoimmune uveitis. Ann. Eye Sci. 2, 19.
< , R. (https://doi.org/10.21037/aes.2017.03.02>
20. 2019) Microbiome and autoimmune uveitis. Front. Immunol. 10, 32.
< , R., Caspi, R. R. (https://doi.org/10.3389/fimmu.2019.00232>
21. 2008) Gut microbiota and liposaccharide content of the diet influence development of regulatory T cells: studies in germ-free mice. BMC Immunol. 9, 65.
< , T., Stepankova, R., Kozakova, H., Hudkovic, T., Tlaskalova-Hogenova, H. (https://doi.org/10.1186/1471-2172-9-65>
22. 2001) The role of microflora in the development of intestinal inflammation: acute and chronic colitis induced by dextran sulfate in germ-free and conventionally reared immunocompetent and immunodeficient mice. Folia Microbiol. (Praha) 246, 565-572.
< , T., Stepankova, R., Cebra, J., Tlaskalova-Hogenova, H. (https://doi.org/10.1007/BF02818004>
23. 2019) Disruption of intestinal homeostasis and intestinal microbiota during experimental autoimmune uveitis. Invest. Ophthalmol. Vis. Sci. 60, 420-429.
< , C., Nakamura, Y. K., Metea, C., Gligor, A., Yu, W., Karstens, L., Rosenbaum, J. T., Asquith, M., Lin, P. (https://doi.org/10.1167/iovs.18-24813>
24. 1993) Detection of T and B cells in many animal species using cross-reactive anti-peptide antibodies. J. Immunol. 150, 5429–5435.
< , M., Cordell, J. L., Beyers, A. D., Tse, A. G., Mason, D. Y. (https://doi.org/10.4049/jimmunol.150.12.5429>
25. 2011) Antibiotic therapy in inflammatory bowel disease: a systematic review and meta-analysis. Am. J. Gastroenterol. 106, 661-673.
< , K. J., Ullman, T. A., Ford, A. C., Abreu, M. T., Marshall, J. K., Talley, N. J., Moayyedi, P. (https://doi.org/10.1038/ajg.2011.72>
26. 2017) Clinical effect of IRT-5 probiotics on immune modulation of autoimmunity or alloimmunity in the eye. Nutrients 9, 11.
, J., Choi, S. H., Kim, Y. J., Jeong, H. J., Ryu, J. S., Lee, H. J., Kim, T. W., Im, S. H., Oh. J. Y., Kim, M. K. (
27. 2013) Altered gut microbiota promotes colitis-associated cancer in IL-1 receptor-associated kinase M-deficient mice. Inflamm. Bowel Dis. 19, 1266-1277.
< , K., Kverka, M., Zakostelska, Z., Hudkovic, T., Hrncir, T., Stepankova, R., Rossmann, P., Ridl, J., Kostvocik, M., Mrazek J., Kopecny, J., Kobayashi., K. S., Tlaskalova- Hogenova, H. (https://doi.org/10.1097/MIB.0b013e318281330a>
28. 2014) Mycophenolate mofetil and cyclophosphamide treatments suppress inflammation intensity in an experimental model of autoimmune uveitis. Folia Biol. (Praha) 60, 228-234.
, A., Seidler Štangová, P., Heissigerová, J., Svozílková, P., Kučera, T. (
29. 2019) Importance of the intestinal microbiota in ocular inflammatory diseases. Clin. Exp. Ophthalmol. 47, 418-422.
< , P. (https://doi.org/10.1111/ceo.13493>
30. 2018) Probiotics in autoimmune and inflammatory disorders. Nutrients 10, 10.
, Y., Allokaran, J. J., Rhoads, J. M. (
31. 2016) Gut microbial alterations associated with protection from autoimmune uveitis. Invest. Ophthalmol. Vis. Sci. 57, 3747-3758.
< , Y. K., Metea, Ch., Karstens, L., Asquith, M., Gruner, H., Moscibrocki, C., Lee, I., Brislawn, C. J., Jansson, J. K., Rosenbaum, J. T., Lin., P. (https://doi.org/10.1167/iovs.16-19733>
32. 2007) Helicobacter pylori: an underestimated factor in acute anterior uveitis and spondyloarthropathies? Ophthalmologica 221, 6-13.
< , L., Zlatanovic, G., Stanojevic-Paovic, A., Miljkovic- Selimovic, B., Dinic, M., Djordjevic-Jocic, J., Stankovic, A. (https://doi.org/10.1159/000096515>
33. 2007) Panretinal, high-resolution color photography of the mouse fundus. Invest. Ophthalmol. Vis. Sci. 48, 2769-2774.
< , M., Guyomard, J. L., Simonutti, M., Roux, M. J., Picaud, S., Legargasson, J. F., Sahel, J. A. (https://doi.org/10.1167/iovs.06-1099>
34. 2010) The role of infections in the pathogenesis and course of multiple sclerosis. Ann. Indian Acad. Neurol. 13, 80-86.
< , S., Sriram, S. (https://doi.org/10.4103/0972-2327.64622>
35. 2010) Metronidazole effects on microbiota and mucus layer thickness in the rat gut. FEMS Microbiol. Ecol. 73, 601-610.
, M. A., Vasquez, N., Balamurugan, R., Pereira, E., Dossou-Yovo, F., Suau, A., Pochart, P., Magne, F. (
36. 2010) Effect of metronidazole and modulation of cytokine production on human periodontal ligament cells. Int. Immunopharmacol. 10, 744-750.
< , A., Paolillo, R., Guida, L., Annunziata, M., Bevilacqua, N., Tufano, M. A. (https://doi.org/10.1016/j.intimp.2010.04.004>
37. 1992) Uveitis and systemic disease. Br. J. Ophthalmol. 76, 137-141.
< , A., Buitenhuis, H. J., Meenken, C., Brinkman, C. J. J., Linssen, A., Alberts, C., Luyendijk, L., Kijlstra, A. (https://doi.org/10.1136/bjo.76.3.137>
38. 2019) An introduction of the role of probiotics in human infections and autoimmune diseases. Crit. Rev. Microbiol. 45, 413-432.
< , H., Soares, S. C., Oliveira, C. J. F. (https://doi.org/10.1080/1040841X.2019.1621261>
39. 2014) Ciprofloxacin affects host cells by suppressing expression of the endogenous antimicrobial peptides cathelicidins and betadefensin- 3 in colon epithelia. Antibiotics 3, 353-374.
< , P., Mily, A., Al Mamun,A., Jalal, S., Bergman, P., Raqib, R., Gudmundsson, G., H., Agerberth, B. (https://doi.org/10.3390/antibiotics3030353>
40. 2011) The microbiome and rheumatoid arthritis. Nat. Rev. Rheumatol. 7, 569-578.
< , J. U., Abramson, S. B. (https://doi.org/10.1038/nrrheum.2011.121>
41. 1998) Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect. Immun. 66, 5224-5231.
< , R. K., Tonkonogy, S., Schultz, M., Dieleman, L. A., Grenther, W., Balish, E., Rennick, D. M., Sartor, R. B. (https://doi.org/10.1128/IAI.66.11.5224-5231.1998>
42. 2013) The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 341, 569-573.
< , P. M., Howitt, M. R., Panikov, N., Michaud, M., Gallini, C. A., Bohlooly-Y, M., Glickman, J. N., Garrett. W. S. (https://doi.org/10.1126/science.1241165>
43. 2019) Loss of gut barrier integrity triggers activation of islet-reactive T cells and autoimmune diabetes. Proc. Natl. Acad. Sci. USA 116, 15140-15149.
< , Ch., Cosorich, I., Lo Conte, M., De Giorgi, L., Facciotti, F., Luciano, R., Rocchi M., Ferrarese, R., Sanvito, F., Canducci, F., Falcone, M. (https://doi.org/10.1073/pnas.1814558116>
44. 2019) Crucial role of microbiota in experimental psoriasis revealed by a gnotobiotic mouse model. Front. Microbiol. 10, 236.
< , Z., Kostovcikova, K., Kverka, M., Rossmann, P., Dvorak, J., Novosadova, I., Kostovcik, M., Coufal, S., Srutkova, D., Prochazkova, P., Hudcovic, T., Kozakova, H., Stepankova, R., Rob, F., Juzlova, K., Hercogova, J., Tlaskalova-Hogenova, H., Jiraskova, Zakostelska, Z. (https://doi.org/10.3389/fmicb.2019.00236>
45. 1996) Recent developments in the treatment of posterior uveitis. Ocul. Immunol. Inflamm. 4, 207-217.
< , M. S. A., Jager, M. J., Kijlstra, A. (https://doi.org/10.3109/09273949609079654>
46. 1997) Oral tolerance in a murine model of relapsing experimental autoimmune uveoretinitis (EAU): induction of protective tolerance in primed animals. Clin. Exp. Immunol. 109, 370-376.
< , S. R., Chan, C., Nussenblatt, R. B., Caspi, R. R. (https://doi.org/10.1046/j.1365-2249.1997.4571356.x>
47. 2004) Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases. Immunol. Lett. 93, 97-108.
< , H., Stepankova, R., Hudcovic, T., Tuckova, L., Cukrowska, B., Lodinova-Zadnikova, R., Kozakova, H., Rossmann, P., Bartova, J., Sokol, D., Funda, D. P., Borovska, D., Rehakova, Z., Sinkora, J., Hofman, J., Drastich, P., Kokesova, A. (https://doi.org/10.1016/j.imlet.2004.02.005>
48. 2010) Reactive arthritis after enteric infections in the United States: the problem of definition. Clin. Infect. Dis. 50, 247-254.
< , J. M. (https://doi.org/10.1086/649540>
49. 2014) Antibiotics associated with increased risk of new-onset Crohn’s disease but not ulcerative colitis: a meta-analysis. Am. J. Gastroenterol. 109, 1728-1738.
< , R., Bernstein, C. N., Gearry, R., Hviid, A., Kolho, K. L., Kronman, M. P., Shaw, S., Van Krujningen, H., Colombel, J. F., Atreja, A. (https://doi.org/10.1038/ajg.2014.246>
50. 2012) Meta-analysis of broad-spectrum antibiotic therapy in patients with active inflammatory bowel disease. Exp. Ther. Med. 4, 1051-1056.
< , S. L., Wang, Z. R., Yang, C. Q. (https://doi.org/10.3892/etm.2012.718>
51. 2008) Innate immunity and intestinal microbiota in the development of type 1 diabetes. Nature 23, 1109-1113.
< , L., Ley, R. E., Volchkov, P. Y., Stranges, P. B., Avanesyan, L., Stonebraker, A. C., Hu, C., Wong, F. S., Szot, G. L., Bluestone, J. A., Gordon, J. I., Chervonsky, A. V. (https://doi.org/10.1038/nature07336>
52. 2008) A clinical grading system for retinal inflammation in the chronic model of experimental autoimmune uveoretinitis using digital fundus images. Exp. Eye Res. 87, 319-326.
< , H., Koch, P., Chen, M., Lau, A., Reid, D.M., Forrester, J.V. (https://doi.org/10.1016/j.exer.2008.06.012>
53. 2016) Intestinal microbiota promotes psoriasis-like skin inflammation by enhancing Th17 response. PLoS One 11, 7.
< , Z., Malkova, J., Klimesova, K., Rossmann, P., Hornova, M., Novosadova, I., Stehliková, Z, Kostovcik, M., Hudcovic, T., Stepankova, R., Juzlova, K., Hercogova, J., Tlaskalova-Hogenova, H., Kverka, M. (https://doi.org/10.1371/journal.pone.0159539>